The discovery of epidermal growth factor receptor gene (EGFR) mutations, first reported in early 2000s, changed that mentality with a number of other mutations/fusions reported subsequently transforming NSCLC into a genomic disease. Here, EGFR is linked to non-small cell lung carcinoma.